IL94417A - Pharmaceutical compositions containing gestodene for the treatment of carcinoma - Google Patents

Pharmaceutical compositions containing gestodene for the treatment of carcinoma

Info

Publication number
IL94417A
IL94417A IL9441790A IL9441790A IL94417A IL 94417 A IL94417 A IL 94417A IL 9441790 A IL9441790 A IL 9441790A IL 9441790 A IL9441790 A IL 9441790A IL 94417 A IL94417 A IL 94417A
Authority
IL
Israel
Prior art keywords
cells
gestodene
steroids
treatment
antiestrogen
Prior art date
Application number
IL9441790A
Other languages
English (en)
Other versions
IL94417A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL94417A0 publication Critical patent/IL94417A0/xx
Publication of IL94417A publication Critical patent/IL94417A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL9441790A 1989-05-17 1990-05-16 Pharmaceutical compositions containing gestodene for the treatment of carcinoma IL94417A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3916381A DE3916381A1 (de) 1989-05-17 1989-05-17 Verwendung von gestoden zur herstellung von arzneimitteln

Publications (2)

Publication Number Publication Date
IL94417A0 IL94417A0 (en) 1991-03-10
IL94417A true IL94417A (en) 1995-07-31

Family

ID=6381002

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9441790A IL94417A (en) 1989-05-17 1990-05-16 Pharmaceutical compositions containing gestodene for the treatment of carcinoma

Country Status (15)

Country Link
EP (1) EP0399631B1 (de)
JP (1) JPH0386826A (de)
CN (1) CN1047298A (de)
AT (1) ATE101519T1 (de)
AU (1) AU640139B2 (de)
CA (1) CA2016895A1 (de)
DD (1) DD298883A5 (de)
DE (2) DE3916381A1 (de)
DK (1) DK0399631T3 (de)
ES (1) ES2062312T3 (de)
HU (1) HUT54501A (de)
IE (1) IE65717B1 (de)
IL (1) IL94417A (de)
PT (1) PT94051B (de)
ZA (1) ZA903803B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
FR2833837B1 (fr) * 2001-12-21 2005-08-05 Oreal Composition pour la teinture d'oxydation des fibres keratiniques comprenant un amide d'acide gras de colza oxyethylene
JP4775563B2 (ja) * 2006-03-31 2011-09-21 Ｎｏｋ株式会社 センターベアリングサポート
JP2009078123A (ja) 2007-09-07 2009-04-16 Morito Co Ltd 取付部品と取付対象物との連結方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren

Also Published As

Publication number Publication date
ATE101519T1 (de) 1994-03-15
DK0399631T3 (da) 1994-06-06
PT94051A (pt) 1991-01-08
CA2016895A1 (en) 1990-11-17
HU903055D0 (en) 1990-09-28
HUT54501A (en) 1991-03-28
IL94417A0 (en) 1991-03-10
AU640139B2 (en) 1993-08-19
DD298883A5 (de) 1992-03-19
DE69006633D1 (de) 1994-03-31
CN1047298A (zh) 1990-11-28
AU5513590A (en) 1990-11-29
ES2062312T3 (es) 1994-12-16
DE69006633T2 (de) 1994-08-25
IE901775L (en) 1990-11-17
ZA903803B (en) 1991-03-27
EP0399631A1 (de) 1990-11-28
EP0399631B1 (de) 1994-02-16
IE65717B1 (en) 1995-11-15
JPH0386826A (ja) 1991-04-11
DE3916381A1 (de) 1990-11-22
PT94051B (pt) 1996-11-29

Similar Documents

Publication Publication Date Title
HORWITZ The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells
Schoonen et al. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines
JP2656958B2 (ja) ホルモン依存性腫瘍治療剤
Kuhl Pharmacokinetics of oestrogens and progestogens
JP3441459B2 (ja) ホルモン補充のための薬剤の調整方法
Kloosterboer et al. Effects of progestagens and Org OD14 in in vitro and in vivo tumor models
Gompel et al. In vitro studies of tibolone in breast cells
Ottosson Oral progesterone and estrogen/progestogen therapy: effects of natural and synthetic hormones on subfractions of HDL cholesterol and liver proteins
JPH10513152A (ja) 抗黄体ホルモンおよびプロゲスチンを含有する周期相ホルモン養生法
CN1358104A (zh) 低剂量雌激素间断激素补偿治疗
CA2326654A1 (en) Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
JP2005538150A (ja) エストロゲン補充療法
KR20090067198A (ko) 자궁내막 증식을 억제하는 조성물과 방법
JP2002521452A (ja) ホルモン代替治療のための生物由来エストロゲンスルファメートの使用
EP0754456B1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
Manni et al. Effects of progestins on growth of experimental breast cancer in culture: interaction with estradiol and prolactin and involvement of the polyamine pathway
Lane et al. Effects of dydrogesterone on the oestrogenized postmenopausal endometrium
Vermeulen et al. Metabolic effects of the triphasic oral contraceptive TrigynonR
EP0399631B1 (de) Verwendung von Gestoden zur Herstellung von Arzneimitteln
Campagnoli et al. Conjugated estrogens and breast cancer risk
Mauvais-Jarvis et al. Antiestrogen action of progesterone in breast tissue
Phillips The selectivity of a new progestin
Sitruk-Ware Hormone therapy and the cardiovascular system: the critical role of progestins
CN107007611B (zh) 醋酸诺美孕酮在制备治疗子宫内膜癌的药物中的应用
Everson et al. Estradiol Mustard (NSC-112259) and Phenester (NSC-116785): Possible Mediation of Action by Estrogen Binding Protein 1, 2, 3

Legal Events

Date Code Title Description
RH Patent void